Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2007
05/03/2007US20070099885 Antibacterial macrocycles with substituted biphenyl
05/03/2007US20070098643 Oligomers of gadolinium chelates, their applicationascontrast products in magnetic resonance imaging and their synthesis intermediates
05/03/2007US20070096084 comprising N,N'-diaryl-substituted-1,4,5,8-naphthalene tetracarboxylic acid diimide compound; integrated circuits; solar cells
05/03/2007DE102005051514A1 New amino-pyridinoazine derivatives, useful as fungicides for protection of plants and materials, also new intermediates in their synthesis
05/03/2007CA2628074A1 Aminodihydrothiazine derivative
05/03/2007CA2627489A1 Benzo[b]thiophen derivative and process for their production
05/03/2007CA2627403A1 Imidazo-pyridine containing beta agonists, method for producing them and their use as drugs
05/03/2007CA2627325A1 3-hydroxymethylbenzo[b]thiophene derivative and method for producing same
05/03/2007CA2626956A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
05/03/2007CA2626928A1 A 4-oxo-1- (3-substituted phenyl) -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4-inhibitor and a method of preparing same
05/02/2007EP1780201A2 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
05/02/2007EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands
05/02/2007EP1780191A1 Fluorene derivative and organic electroluminescent device using same
05/02/2007EP1778688A1 Antibacterial agents
05/02/2007EP1778687A2 Fused ring heterocycle kinase modulators
05/02/2007EP1778686A2 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
05/02/2007EP1778685A1 Indolizine carboxamides and the aza and diaza derivatives thereof
05/02/2007EP1778680A2 Spirocyclic cyclohexane derivatives
05/02/2007EP1778225A2 Pyrrolo(oxo)isoquinolines as 5ht ligands
05/02/2007EP1549637B1 1- (indol-3-yl)carbonyl piperazine derivatives
05/02/2007EP1480979B1 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
05/02/2007EP1461338B1 Improved process for the preparation of 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-one
05/02/2007EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
05/02/2007EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof.
05/02/2007EP1268478B1 Phenyl-substituted imidazopyridines
05/02/2007EP0869968B1 Growth-hormone secretagogues
05/02/2007CN1956987A Heterocyclic compounds and their use as aldosterone synthase inhibitors
05/02/2007CN1956986A 6-substituted pyridoindolone derivatives, production method and therapeutic use thereof
05/02/2007CN1956971A Novel fused heterocycles and application thereof
05/02/2007CN1956957A Method for the production of a-chloroalkylpyridyl ketones and/or the hydrochlorides thereof
05/02/2007CN1956238A Luminescent element material and luminescent element comprising the same
05/02/2007CN1956237A Luminescent element material and luminescent element comprising the same
05/02/2007CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents
05/02/2007CN1955179A [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents
05/02/2007CN1955178A New benzimidazole derivative
05/02/2007CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/02/2007CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
05/02/2007CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof
05/01/2007US7211672 PGD2 receptor antagonists for the treatment of inflammatory diseases
05/01/2007US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents
05/01/2007US7211597 Antiinflammatory agents; rheumatic diseases; anticancer agents
05/01/2007US7211583 Substituted azaindole as drugs and enzyme inhibitors
05/01/2007US7211581 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
05/01/2007US7211580 Compounds, compositions, and methods
05/01/2007US7211572 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
05/01/2007CA2283587C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with n- or c-linked imidazoles
05/01/2007CA2244836C Benzoheterocyclic derivatives as antidiabetic and antiobesity agents
04/2007
04/26/2007WO2007048070A2 Pyrrolo-pyridine derivatives for the treatment of cancer diseases
04/26/2007WO2007047671A2 Tetrahydroquinolines, synthesis thereof, and intermediates thereto
04/26/2007WO2007047047A2 Polymorph transformation of zolpidem in tablet matrix
04/26/2007WO2007045758A1 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
04/26/2007WO2007045392A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases
04/26/2007WO2007045096A1 Oligoheteroaromatic luminiscent assemblies as high-affinity dna sequence-directed ligands
04/26/2007WO2007023382A3 Pyrimidine amino pyrazole compounds, potent kinase inhibitors
04/26/2007WO2006120133A3 Process for coloring keratin fibers comprising metal complexes
04/26/2007WO2004101566A8 Novel intermediate for the preparation of therapeutically active imidazopyridines
04/26/2007WO2004099203A8 Imidazopyridine intermediates
04/26/2007US20070093652 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands
04/26/2007US20070093512 4-Phenylaminopyrido[4,3-d]pyrimidines 6-heteroaryl-substituted, in which the heteroaryl is substituted with a sulfonylethylamino-, thio- or oxy- group; protein tyrosine kinase inhibitors, used especially to treat various malignancies
04/26/2007US20070093500 adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms; 4,5,6,7-tetrafluoro-2-{4-[4-(2-isopropoxy-phenyl)-piperazin-1-yl]-cyclohexyl}-isoindole-1,3-dione
04/26/2007US20070093496 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors
04/26/2007US20070093491 Novel condensed n-pyrazinyl-sulphonamides and their use in the treament of chemokine mediated diseases
04/26/2007US20070093485 Substituted n-phenyl sulfonamide bradykinin antagonists
04/26/2007US20070093480 e.g. 2 {5,6-dimethoxy-1-[2-(4-methylpiperazin- 1 -yl)ethyl]-1H-indol-3 -yl}-1H-pyrrolo[2,3- b]pyridine; Insulin Growth Factor-1 (somatomedin) antagonist; antiproliferative, antitumor agent; solid tumor; prostate, lung and breast cancer
04/26/2007US20070093379 Metal catalysts (preferably manganese-containing catalysts) complexed with selected macropolycyclic rigid ligands, preferably cross-bridged macropolycyclic ligands; useful for oxidative synthetic chemistry processes, bleaching of pulp and paper products
04/26/2007US20070089641 preparing a mixture of (2,3-bis-substituted anilino)-but-2-ene-1,4-dioc acid derivatives comprising the step of combining, in any order, a reagent having the formula Ar NH CH(COX) CO COY (I) ( Ar= phenyl, X and Y OCH3 ) and a substituted aniline, in a solvent ; cyclization: asymmetric quinolonoquinolone
04/26/2007CA2626242A1 Polymorph transformation of zolpidem in tablet matrix
04/26/2007CA2626215A1 Tetrahydroquinolines, synthesis thereof, and intermediates thereto
04/26/2007CA2625442A1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases
04/25/2007EP1777226A1 [1,7]naphthyridines as pde4 inhibitors
04/25/2007EP1777223A1 Indole derivatives useful as histamine H3 antagonists
04/25/2007EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives
04/25/2007EP1776368A1 Inhibitors of hcv replication
04/25/2007EP1776362A1 Spiro compounds and methods for the modulation of chemokine receptor activity
04/25/2007EP1776361A1 5-substituted 1h-pyrroloý3,2-b¨pyridines
04/25/2007EP1401449B1 Tetracyclic compounds as pde5-inhibitors
04/25/2007EP1315710B1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
04/25/2007EP1305294B1 Imidazolyl derivatives
04/25/2007EP1024138B1 Pyrazole derivatives
04/25/2007CN1953985A Prodrugs of piperazine and substituted piperidine antiviral agents
04/25/2007CN1953983A 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
04/25/2007CN1953982A 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones
04/25/2007CN1953979A Substituted 5,12-diaza-benzoanthracene analogues
04/25/2007CN1953978A 5-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b] indol-2-ones and analogs as anti-virals
04/25/2007CN1953976A Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
04/25/2007CN1953747A Diphenyl-indol-2-on compounds and their use in the treatment of cancer
04/25/2007CN1951939A Novel pyrrole derivatives as pharmaceutical agents
04/25/2007CN1951938A Penehyclidine quaternary ammonium salt and its derivative
04/25/2007CN1951917A Pyridinone derivatives for treatment of atherosclerosis
04/25/2007CN1312154C Purine derivatives as kinase inhibitors
04/25/2007CN1312131C Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent
04/25/2007CN1312127C 2-cyano-4-fluoropyrrolidine derivative or its salt
04/25/2007CN1311988C Imide compounds and optical recording media made by using the same
04/25/2007CN1311828C Use of CGMP phosphodiesterase inhibitor for treating sexual impotence
04/24/2007USRE39590 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione; useful for general or pre-emergent or post-emergent control of undesired plant species and defoliants at very low concentrations
04/24/2007US7208602 N-sulfonyl- azetidines, pyrrolidines, piperidines and hexamethylenimines; treatment and prevention of Alzheimer's Disease and other diseases relating to the deposition of amyloid protein.
04/24/2007US7208504 Bicyclic inhibitors of hormone sensitive lipase
04/24/2007US7208501 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders
04/24/2007US7208498 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
04/24/2007US7208494 5HT2c receptor agonists